The future is now – and the work of your team has never been more important. Your teams' health and well-being are essential to enabling them to perform at their highest potential, as well as the happiness of your population. As a strategic pharmacy and health services partner, we are committed to making health care more affordable, simple and predictable.
Nissan
Nissan, thank you for considering Express Scripts as your pharmacy partner. For your reference, I have included some sample documents to exemplify how easy it is to work with Express Scripts. Please feel free to share this site with your peers and let me know if you have any questions or desire additional information. On behalf of the entire Express Scripts team, I look forward to the prospect of working with you to improve the health and happiness of your employees and their families for years to come.
Diabetes Remote Monitoring
Beyond the clinical advantages of remote monitoring, we are seeing significant health savings for clients and their members, reducing the cost of medical care for patients with hypertension and associated chronic conditions, like diabetes.
Health Connect 360: Better Health Outcomes – Guaranteed
Express Scripts offers the industry's first outcomes-based model of care that guarantees clinical targets and connects patient touchpoints across the care continuum.
Pulmonary Remote Monitoring
Our pulmonary remote monitoring program is increasingly important to patients because COVID-19 infection can cause lasting lung damage. This vetted digital tool allows patients to optimally manage their asthma and COPD by ensuring they use their inhalers as directed, minimizing the chances of lung damage and other severe complications.
See how innovation comes to life at the Express Scripts Lab
The Lab is a collaborative space where we innovate and ideate with clients to develop solutions that improve care and reduce costs.
Diabetes Remote Monitoring
By using rigorous data analytics and clinical insights, our diabetes remote monitoring helps identify patients who are on the path toward a diagnosis of diabetes or coronary heart disease, then supports them on their journey to better health and lowers their risk of experiencing COVID-19 complications.
SaveOnSp drives maximum savings
See how our first-to-market program drives repeated year-over-year impact.
Therapeutic Resource Centers® (TRCS)
Individual centers of focused expertise.
Making pharma work harder with SafeGuardRx
Our first-to-market answer to the call for value-based payment strategies, unlocking new financial value and better health outcomes.
Drug Trend Report
In the face of the COVID-19 crisis, we worked together with clients to solve urgent and emerging needs with innovation, agility and focus while delivering results. See a snapshot of what we were able to help our clients achieve.
Focus on fertility and family planning
COVID-19 changed our lives and challenged us in ways we've never expected. As a trusted health care partner to plan sponsors, we sought to understand how the pandemic has impacted women's attitudes and behaviors around family planning – as well as assess the need for related benefits. While some have predicted a baby bust, our survey of 2,000 women between ages 25-45 with employer-sponsored benefits found that most respondents who maintained health insurance also maintained their goals to build families.
of women report interest in additional fertility benefits from their insurance plan or employer1
of respondents would change jobs, or encourage their partner to do so, for pregnancy, fertility and adoption coverage1
of respondents would change jobs, or encourage their partner to do so, for pregnancy, fertility and adoption coverage2
SafeGuardRx® Weight Management Care Value Program
While some still see obesity as a cosmetic issue or physical inconvenience, the health impact is devastating to members, plan sponsors and the nation. It’s time to start winning the losing battle - introducing WegovyTM + MDLIVE for the win.
of American adults is obese3
of medical spend is for obesity related illnesses4
of the U.S. population will be obese by 20305
Expect more from Express Scripts
These sample assets will provide a sense of what to expect in terms of onboarding and implementation, should you select Express Scripts as your pharmacy partner, as well as the benefits and insights you can look forward to as a client. I hope you find this information useful and, as always, please reach out with any questions.
Sample Implementation Timeline
Curious of what to expect as you consider moving to Express Scripts? Our experienced teams are thorough and skilled in seamlessly implementing large and complex plans. Review a sample implementation plan for more details.
Sample Member Communications
We provide timely and comprehensive communications to ensure access and affordability for your members, and minimized noise for your plan.
Sample Strategic Planning Reviews
At Express Scripts, we're committed to taking on your plan's toughest challenges, as well as identifying your greatest opportunities. We're here to ensure your success today and in the future - not just manage your claims. See what you can look forward to during strategic planning.
Sample Reporting
We supply robust and timely reporting metrics to ensure you have a clear line of sight to what's going on with your plan at all times.
Member Mobile Demo
Get a sneak peek of the members' experience with our mobile application. Please use Chrome or Firefox for the best experience.
Open Enrollment Web Demo
Learn more about managing your pharmacy benefits through our open enrollment demo. Please use Chrome or Firefox for the best experience.
Digital Tools and Resources
Get real-time access to operational systems needed to administer your benefit – as well as web-based reporting and analytics, news, resources, industry information, user guides, trainings and more.
Don't take our word for it...
Get our clients' perspectives on what it's like to work with Express Scripts. In this video, you'll hear from Emily Maher of Land O'Lakes.
Hear about our clients' experience with implementation
Find out first hand what you can expect should you select Express Scripts as your pharmacy partner.
Helpful resources to manage your plan
Explore the latest content and tools focused on helping you navigate changes in the dynamic health care industry.
Evernorth solutions
Embarc Benefit Protection℠
Gene therapy has the potential to change lives, but even a single treatment can cost millions of dollars. Embarc Benefit Protection shields members from these high costs, so that people who need treatment can get it.
Healthy Ways to Work
In a world dramatically changed by COVID-19, we’re helping our partners and their employees navigate new realities. Explore agile solutions focused on helping people return to a healthy, safe, and productive workplace.
FamilyPath℠
By 2025, 10 million couples will have trouble starting a family. FamilyPath is raising the bar for fertility health by providing more comprehensive, more flexible coverage and proactive care for growing families.
inMynd℠
Advancing mental health with a behavioral health care solution that complements any existing traditional employee assistance programs (EAPs) or wellness initiatives with medication-focused treatments to create a holistic approach to mental health care.
Digital Health Formulary
With more than 200 new digital health solutions each day, navigating the digital health landscape is confusing, costly and time-consuming. The Digital Health Formulary helps you manage the fast-growing world of digital health.
Understand your risk
In this uncertain time, we provide unwavering support to help plan sponsors provide their members with the medications they need to get and stay healthy, and make informed decisions to protect the health and well-being of their employees. As you make decisions on behalf of your business and your employees, our COVID-19 Risk Dashboard can help you understand your unique risks.
Protecting your members in a time of uncertainty
In this uncertain time, we provide unwavering support to help plan sponsors provide their members with the medications they need to get and stay healthy, and make informed decisions to protect the health and well-being of their employees.
References
1. “Assessing COVID-19’s Impact on Women’s Attitudes and Behaviors toward Family Planning,” Online survey among 2,000 women with employer-sponsored insurance, Evernorth, November 2020
2. Assessing Perception of and the Need for Enhanced Fertility Solutions,” Quantitative Research Study, Express Scripts, March 2020
3. Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA. 2012;307:491-7.
4. Cawley J, Meyerhoefer C. The medical care costs of obesity: an instrumental variables approach. Journal of Health Economics. 31(1):219-230. 2012
5. Ward, Zachary J. and Bleich, Sara N. and Cradock, Angie L. and Barrett, Jessica L. and Giles, Catherine M. and Flax, Chasmine and Long, Michael W. and Gortmaker, Steven L.(December 19, 2019). Projected U.S. State-Level Prevalence of Adult Obesity and Severe Obesity. New England Journal of Medicine, 381:2440-2450.
1. “Assessing COVID-19’s Impact on Women’s Attitudes and Behaviors toward Family Planning,” Online survey among 2,000 women with employer-sponsored insurance, Evernorth, November 2020
2. Assessing Perception of and the Need for Enhanced Fertility Solutions,” Quantitative Research Study, Express Scripts, March 2020
3. Flegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA. 2012;307:491-7.
4. Cawley J, Meyerhoefer C. The medical care costs of obesity: an instrumental variables approach. Journal of Health Economics. 31(1):219-230. 2012
5. Ward, Zachary J. and Bleich, Sara N. and Cradock, Angie L. and Barrett, Jessica L. and Giles, Catherine M. and Flax, Chasmine and Long, Michael W. and Gortmaker, Steven L.(December 19, 2019). Projected U.S. State-Level Prevalence of Adult Obesity and Severe Obesity. New England Journal of Medicine, 381:2440-2450.